
César Milstein
Argentine biochemist, co-discoverer of monoclonal antibodies and Nobel laureate in Physiology or Medicine in 1984 · 1927–2002
- Born
- October 8, 1927
- Died
- March 24, 2002
- Country
- United Kingdom, Argentina
- Section
- Biology
- Awards
- Nobel Prize in Physiology or Medicine
Biography
César Milstein (Bahía Blanca, 1927 – Cambridge, 2002) was an Argentine biochemist who shared the 1984 Nobel Prize in Physiology or Medicine for developing monoclonal antibodies, a tool that transformed biological research and medicine in the following decades. He was trained in Argentina, but most of his career took place in England, at the University of Cambridge, where he worked for almost half a century and became one of the central figures in the study of antibodies.
He was born on 8 October 1927 in Bahía Blanca, into a Jewish family. His father, Lázaro Milstein, was a Ukrainian-born immigrant who had reached Argentina in 1913, and his mother, Máxima Vapñarsky, was a schoolteacher. César was the second of three brothers. His father later recalled him as a mischievous, somewhat rebellious and very clever boy, who did not study much but got on well at school.
He attended primary school in Bahía Blanca and secondary school at the town's national college. At the age of 13 he read The Microbe Hunters by Paul de Kruif, a popular account of the lives of biologists such as Pasteur and Koch, which sparked an interest that never left him. He then moved to Buenos Aires to study at the University of Buenos Aires.
He graduated in chemistry from the Faculty of Exact and Natural Sciences at the age of 25. In 1956 he obtained his doctorate with a thesis on enzymes, the proteins that speed up chemical reactions inside living things, and he received a prize from the Argentine Society for Biochemical Research for that work. As a young man he was active in the anarchist movement, a part of his life that shaped his student years.
In 1958, with funding from the British Council, he arrived at the University of Cambridge to pursue a further doctorate under Malcolm Dixon, studying how metals activate the enzyme phosphoglucomutase. During this period he collaborated with Frederick Sanger, the Nobel chemist, whose research group became a shared workspace for him. In 1961 he returned to Argentina to head the Division of Molecular Biology at the National Institute of Microbiology, but he stayed in the post for only a year. After the military coup of 1962 he went back to England, and he did not return to live in the country.
At Cambridge he joined the Laboratory of Molecular Biology of the Medical Research Council, where he studied immunoglobulins, the proteins that make up antibodies. Antibodies are the molecules the immune system produces to recognise and neutralise foreign substances, known as antigens. The difficulty was that exposing an organism to an antigen produces a mixture of different antibodies, which makes it hard to study each one on its own.
In 1975 he worked with Georges Köhler, a postdoctoral fellow in his laboratory, on a technique that addressed this problem. It involved fusing antibody-producing cells with tumour cells from myeloma, creating hybrid cells called hybridomas that could keep making a single type of antibody indefinitely. That identical antibody became known as monoclonal. The impact was enormous: monoclonal antibodies are now used as laboratory tools, in diagnosis and as medicines. In 1983 he was appointed head and director of the Division of Chemistry, Proteins and Nucleic Acids at Cambridge.
He shared the 1984 Nobel Prize with Köhler and with Niels Kaj Jerne. Accounts differ on patents: one states that he did not patent the technique that earned the prize, while another claims that he patented its production. What is documented is that some of his other discoveries were patented, with the benefits going to the institutions that had funded them. In 1986 he co-founded Medicorp Sciences, a biotechnology company based in Montreal, together with the Argentine scientist Claudio Cuello and the entrepreneur Martín Varsavsky. The firm pioneered tests to detect AIDS, cancer and the PSA antigen.
In 1987 the National University of the South awarded him an honorary doctorate, which was presented to him in December that year during a visit to Bahía Blanca. In 1993 he received the Konex Diamond Award, shared with the surgeon René Favaloro. On 15 December 1999 he gave one of his last talks, at the Faculty of Exact Sciences of the University of Buenos Aires, under the title Curiosity as a Source of Wealth.
In 1953 he married Celia Prilleltensky, with whom he had worked on early studies of antibody diversity. Milstein died in Cambridge on 24 March 2002, aged 74, from a heart condition he had suffered from for many years.
His legacy goes beyond his discoveries. He acted as a guide and an inspiration to many researchers in the field and devoted effort to supporting scientists in less developed countries. He also anticipated the potential of applying recombinant DNA technology to antibodies, which helped launch the field of antibody engineering. In 2021 the Argentine government declared the year a tribute to his commitment to science, and in 2010 the documentary Un fueguito, directed by his great-niece Ana Fraile, was released. It received the award for Best Documentary from the Argentine Academy of Cinema.
Main contributions
- 1975Monoclonal antibodies: a technique for mass-producing identical antibodies, developed with Georges Köhler by fusing antibody-producing cells with tumour cells.
- 1986Diagnostic tests: through Medicorp Sciences, the company he co-founded, he helped develop tests for AIDS, cancer and the PSA antigen.
- Studies on antibody diversity: he investigated their structure at the level of amino acids and the disulfide bonds that hold their chains together.
- Somatic hypermutation: he showed the importance of localised mutations in immunoglobulin genes for improving antibody affinity, a process known as affinity maturation.
- Monoclonal antibodies as probes in neurological disease: together with Claudio Cuello he laid the groundwork for using them to study the pathological pathways of these disorders.
- Antibody engineering: he anticipated that recombinant DNA technology could produce safer and more effective monoclonal antibodies for use as medicines.
Teachers and students
Trivia and anecdotes
A book at 13
Reading The Microbe Hunters by Paul de Kruif in his teens drew him towards biology.
A story that named a film
For his funeral, his great-niece Ana Fraile chose a story by Eduardo Galeano, Un mar de fueguitos, which later gave its name to the film about his life.
Prize for the decade
In 1993 the Konex Foundation named him the most important scientist in Argentina over the previous decade, according to the foundation's award.
Their contemporaries
While César Milstein was alive (1927–2002)…
Alive at the same time
Discovered or invented in those years
- 1931Big BangA cosmological model describing how the universe expanded from an early state of extreme density and temperature, about 13.8 billion years ago.
- 1932NeutronA subatomic particle with no net electric charge, found in the nucleus of almost every atom alongside protons.
- 1945ComputerA programmable machine that takes in data, processes it by following stored instructions, and produces results, able to switch tasks simply by running different software.
- 1969InternetA global network of interconnected computer networks that communicate using the TCP/IP protocol suite.
- 1973Mobile phoneA handheld wireless phone that lets people make and receive calls while moving across a cellular network area.
- 1989World Wide WebA system of linked documents and resources, connected by hyperlinks and accessed over the Internet with web browsers.
Sydney Brenner1927–2019 · Biology
Marshall Warren Nirenberg1927–2010 · Biology
James Watson1928–2025 · Biology
Carl Woese1928–2012 · Biology
Paul Berg1926–2023 · Biology
Edward O. Wilson1929–2021 · Biology